National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Ikervis® is indicated for the treatment of severe keratitis in adult patients with dry eye disease (DED), which has not improved despite treatment with tear substitutes.

Rapid Review

Commenced Completed Outcome
07/01/2015 18/01/2016 Full Pharmacoeconomic Evaluation Not Recommended